Endocyte receives $3.5 million for cancer treatments

11/17/2004 | Journal Gazette (Fort Wayne, Ind.), The

Endocyte, a biotech company involved in chemotherapeutics aimed at cancer cells, has been awarded $3.5 million in federal and state grants to finish research expected to lead to clinical trials. The West Lafayette, Ind., company hopes to be able to stimulate cancer cells to take in vitamin foliate molecules treated with anti-cancer drugs, allowing the treatment to avoid harming normal cells.

View Full Article in:

Journal Gazette (Fort Wayne, Ind.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT